News
Adjusted EBITDA totaled $ (19.3) million in the second quarter of fiscal 2025, compared to Adjusted EBITDA of $ (26.5) million in the second quarter of fiscal 2024. Please see the discussion of ...
Novo Nordisk today announced that new hemophilia data will be presented at the upcoming International Society on Thrombosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback